According to the latest report by IMARC Group, “Global Infertility Drugs Market Size, Share, Growth, Industry Trends, Opportunity and Forecast 2022-2027“, the global infertility drugs market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
Infertility drugs are medicines used to cure infertility and improve the reproductive health of an individual. They are either consumed orally or injected to enhance the quality of sperm and restore the testosterone level in males. In contrast, they stimulate ovulation and follicle development of the ovary in females.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
|Base Year: 2021|
|Forecast Year: 2022-2027|
Infertility Drugs Market Trends and Drivers:
One of the primary factors driving the market is the rising prevalence of infertility, miscarriage, polycystic ovary syndrome (PCOS) cases, breast and urinary cancers, diabetes, obesity and thyroid. Additionally, the sedentary lifestyles and delayed pregnancies are declining the fertility rates, thus propelling the market growth. Besides this, the consumption of alcohol, drugs and smoking is accelerating the adoption rates. Furthermore, extensive investment in the research and development (R&D) activities and various initiatives taken by governments of different nations to spread awareness about the availability of these treatments are escalating the product demand.
Moreover, rising public funding for developing these drugs and rapid approvals from regulatory bodies are creating a positive market outlook. Several other growth-inducing factors include the expanding healthcare industry, rising disposable income levels, technological upgradations, rapid urbanization, and increasing demand for generic medicines.
Global Infertility Drugs Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.
Request Free Sample Report: https://www.imarcgroup.com/infertility-drugs-market/requestsample
The report has segmented the market on the basis of region, drug class, route of administration, distribution channel and end user.
Breakup by Drug Class:
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
Breakup by Route of Administration:
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
Breakup by End User:
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800